While major advances in leukemia diagnosis and treatment were achieved in the last 50 years, especially in childhood leukemia, this group of diseases remains a very serious medical problem. According to the NCI's Surveillance, Epidemiology, and End Results Program (SEER) statistical data, it is estimated that in 2024 there will be a total of 62,770 new cases of leukemia in the U.S., and that 23,670 people will die of this disease. In 2017-2021, the average annual incidence rate of leukemia in the United States was 14.1 per 100,000, and the average annual observed death rate was 5.9 per 100,000 based on years 2018-2022. The first round of Specialized Programs of Research Excellence (SPORE) applications in leukemia took place in 2002, with the subsequent award of the first Leukemia SPORE in 2003.
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at opm.gov.
